Elevation Oncology (NASDAQ:ELEV) Price Target Cut to $1.00 by Analysts at HC Wainwright
Elevation Oncology (NASDAQ:ELEV – Free Report) had its price objective trimmed by HC Wainwright from $6.00 to $1.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Elevation Oncology’s FY2029 earnings at ($0.40) EPS. A number of other […]
Elevation Oncology (NASDAQ:ELEV – Free Report) had its price objective trimmed by HC Wainwright from $6.00 to $1.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Elevation Oncology’s FY2029 earnings at ($0.40) EPS. A number of other […]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
